In this respect, increased CRP to albumin ratio (CAR) or its variant, Glasgow Prognostic Score (GPS), have previously been linked to a worse survival rate in NSCLC patients treated with various oncological strategies [15, 16]. This evidence concerns the gene CRP and non-small cell lung carcinoma.